UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...
Long-term data on the treatment of children and adults living with Lennox-Gastaut syndrome (LGS) with fenfluramine1 demonstrated sustained reduction in frequency of seizures associated with a fall and ...
Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...
A Pride of Britain finalist from Middle Barton will look to set a new world record when she takes part in a half marathon in London this weekend.
US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...
Biogen (BIIB) and Stoke Therapeutics (STOK) announced the presentation of longer-term follow-up analyses from the ongoing open-label extension ...
Stoke Therapeutics (STOK) and Biogen (BIIB) announced the presentation of longer-term follow-up analyses from the ongoing open-label extension ...
U.S. Rep. Chuck Edwards spoke to his District 11 constituents in Flat Rock, Brevard and Saluda. These are the concerns they ...
OVID reported positive phase 1 results for OV329, a next-generation GABA-AT inhibitor targeting drug-resistant focal onset ...
Despite living with the rare Dravet syndrome, Dixon Cribb's mother said he approached life with courage and joy. Photo / Supplied Nine-year-old Dixon Cribb has been remembered for his bright ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback